Mohammed Jaffar

1.6k total citations
39 papers, 1.3k citations indexed

About

Mohammed Jaffar is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Mohammed Jaffar has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Organic Chemistry and 13 papers in Toxicology. Recurrent topics in Mohammed Jaffar's work include Bioactive Compounds and Antitumor Agents (13 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer therapeutics and mechanisms (6 papers). Mohammed Jaffar is often cited by papers focused on Bioactive Compounds and Antitumor Agents (13 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer therapeutics and mechanisms (6 papers). Mohammed Jaffar collaborates with scholars based in United Kingdom, New Zealand and Brazil. Mohammed Jaffar's co-authors include Ian J. Stratford, Edwin C. Chinje, David N. Criddle, Kaye J. Williams, Ole H. Petersen, Alexei V. Tepikin, Michael Chvanov, Robert Sutton, Matthew A. Naylor and Sally Freeman and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Advanced Drug Delivery Reviews.

In The Last Decade

Mohammed Jaffar

38 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Jaffar United Kingdom 19 672 340 234 213 181 39 1.3k
Ladislav Mirossay Slovakia 22 877 1.3× 326 1.0× 172 0.7× 107 0.5× 375 2.1× 79 2.0k
Geetha Achanta United States 9 1.2k 1.8× 510 1.5× 364 1.6× 111 0.5× 400 2.2× 13 2.0k
Marie E. Varnes United States 24 1.3k 1.9× 377 1.1× 316 1.4× 407 1.9× 180 1.0× 67 2.2k
Shin‐Hun Juang Taiwan 25 814 1.2× 360 1.1× 319 1.4× 127 0.6× 327 1.8× 69 2.0k
Wen‐Wei Qiu China 22 1.2k 1.8× 405 1.2× 298 1.3× 83 0.4× 318 1.8× 67 2.1k
Manu Lopus India 24 915 1.4× 309 0.9× 121 0.5× 110 0.5× 516 2.9× 65 1.8k
Raymond E. Counsell United States 23 743 1.1× 354 1.0× 381 1.6× 67 0.3× 152 0.8× 163 2.4k
Thambi Dorai United States 23 1.4k 2.0× 140 0.4× 284 1.2× 54 0.3× 342 1.9× 46 2.2k
Rajagopalan Sridhar United States 17 393 0.6× 172 0.5× 95 0.4× 87 0.4× 140 0.8× 35 913
Shilong Zheng United States 29 1.2k 1.7× 935 2.8× 128 0.5× 97 0.5× 409 2.3× 79 2.3k

Countries citing papers authored by Mohammed Jaffar

Since Specialization
Citations

This map shows the geographic impact of Mohammed Jaffar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Jaffar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Jaffar more than expected).

Fields of papers citing papers by Mohammed Jaffar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Jaffar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Jaffar. The network helps show where Mohammed Jaffar may publish in the future.

Co-authorship network of co-authors of Mohammed Jaffar

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Jaffar. A scholar is included among the top collaborators of Mohammed Jaffar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Jaffar. Mohammed Jaffar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuff, Simone, et al.. (2018). An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells. Free Radical Biology and Medicine. 116. 141–148. 15 indexed citations
2.
Jaffar, Mohammed, et al.. (2017). Analysis of Multilevel Inverter with Different Topologies. International Journal of Engineering Research and. V6(5).
3.
Valente, Cláudia A., Rui Moreira, Rita C. Guedes, et al.. (2007). The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors. Bioorganic & Medicinal Chemistry. 15(15). 5340–5350. 34 indexed citations
4.
Criddle, David N., Stuart Gillies, Mohammed Jaffar, et al.. (2006). Menadione-induced Reactive Oxygen Species Generation via Redox Cycling Promotes Apoptosis of Murine Pancreatic Acinar Cells. Journal of Biological Chemistry. 281(52). 40485–40492. 284 indexed citations
5.
Gbaj, Abdul M, Philip N. Edwards, Philip Reigan, et al.. (2006). Thymidine phosphorylase fromEscherichia coli: Tight-binding inhibitors as enzyme active-site titrants. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(1). 69–73. 18 indexed citations
6.
Jaffar, Mohammed, et al.. (2004). Quinone Bioreductive Prodrugs as Delivery Agents. Current Drug Delivery. 1(4). 345–350. 13 indexed citations
7.
Williams, Kaye J., et al.. (2004). Hypoxia in tumors: molecular targets for anti-cancer therapeutics. Advances in Enzyme Regulation. 44(1). 93–108. 15 indexed citations
8.
Phillips, Roger M., Mohammed Jaffar, Derek J. Maitland, et al.. (2004). Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugs. Biochemical Pharmacology. 68(11). 2107–2116. 37 indexed citations
9.
Stratford, Ian J., Kaye J. Williams, Rachel Cowen, & Mohammed Jaffar. (2003). Combining bioreductive drugs and radiation for the treatment of solid tumors. Seminars in Radiation Oncology. 13(1). 42–52. 19 indexed citations
10.
Jaffar, Mohammed, Roger M. Phillips, Kaye J. Williams, et al.. (2003). 3-Substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitro. Biochemical Pharmacology. 66(7). 1199–1206. 16 indexed citations
11.
Chinje, Edwin C., et al.. (2003). Time-dependence and preliminary SAR studies in inhibition of nitric oxide synthase isoforms by homologues of thiocitrulline. Bioorganic & Medicinal Chemistry Letters. 13(21). 3679–3680. 7 indexed citations
12.
Murray, Paul E., Virginia McNally, S. Lockyer, et al.. (2002). Synthesis and enzymatic evaluation of pyridinium-Substituted uracil derivatives as novel inhibitors of thymidine phosphorylase. Bioorganic & Medicinal Chemistry. 10(3). 525–530. 24 indexed citations
13.
McNally, Virginia, Adam V. Patterson, Kaye J. Williams, et al.. (2002). Antiangiogenic, Bioreductive and Gene Therapy Approaches to the Treatment of Hypoxic Tumours. Current Pharmaceutical Design. 8(15). 1319–1333. 10 indexed citations
14.
Cole, Christian, Philip Reigan, Abdul M Gbaj, et al.. (2002). Potential Tumor-Selective Nitroimidazolylmethyluracil Prodrug Derivatives:  Inhibitors of the Angiogenic Enzyme Thymidine Phosphorylase. Journal of Medicinal Chemistry. 46(2). 207–209. 40 indexed citations
15.
Jaffar, Mohammed, Kaye J. Williams, & Ian J. Stratford. (2001). Bioreductive and gene therapy approaches to hypoxic diseases. Advanced Drug Delivery Reviews. 53(2). 217–228. 41 indexed citations
16.
Criddle, David N., et al.. (2000). Relaxant and Antispasmodic Actions of Methyleugenol on Guinea-Pig Isolated Ileum. Planta Medica. 66(5). 408–411. 48 indexed citations
17.
18.
19.
Cole, Christian, Alison J. Foster, Sally Freeman, et al.. (1999). The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective.. PubMed. 14(5). 383–92. 18 indexed citations
20.
Jaffar, Mohammed, et al.. (1996). The Synthesis of cis‐ and trans‐1,3‐Dimethyl‐4‐Diphenylmethoxypiperidines as Conformationally Restricted Analogues of Diphenylpyraline. Pharmacy and Pharmacology Communications. 2(9). 411–414. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ladislav Mirossay Breakdown of academic impact, for papers by Geetha Achanta Breakdown of academic impact, for papers by Marie E. Varnes Breakdown of academic impact, for papers by Shin‐Hun Juang Breakdown of academic impact, for papers by Wen‐Wei Qiu Breakdown of academic impact, for papers by Manu Lopus Breakdown of academic impact, for papers by Raymond E. Counsell Breakdown of academic impact, for papers by Thambi Dorai Breakdown of academic impact, for papers by Rajagopalan Sridhar Breakdown of academic impact, for papers by Shilong Zheng
Rankless by CCL
2026